MNPR MONOPAR THERAPEUTICS Management Changes 8-K Filing 2025 - Board Changes Michael J. Brown resigned from the Monopar Therapeutics Board on February 19, 2025, and Lavina Talukdar was appointed to the Board on February 21, 2025, bringing over 20 years of experience in investor relations and healthcare investments.Get access to all SEC 8-K filings of the MONOPAR THERAPEUTICS